Search Results

Excel file with national estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved. It includes visits involving...

This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...

This Drug Abuse Warning Network (DAWN) short report summarizes key findings about drug-related emergency department visits between 2004 and 2011. The report includes data for illicit drugs, alcohol, and prescription and over-the counter medications. For medications, the report looks at misuse and abuse, adverse reactions, and accidental ingestion of drugs...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,

This National Survey on Drug Use and Health (NSDUH) short report shows inhalant use by adolescents 12 to 17 years old. It also looks at inhalant use by gender, race, region of the country, metro area, past year use and days used.

These detailed tables present standard errors for totals and prevalence estimates of risk and protective factors regarding substance use from the 2012 National Survey on Drug Use and Health (NSDUH). The factors include perceptions of 1) risk of substance use, 2) availability of substances, 3) parental disapproval of youth substance...

These detailed tables are population tobacco and alcohol use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Tobacco products include cigarettes, smokeless tobacco, cigars, and pipe tobacco. Alcohol use includes binge and heavy alcohol use. Results are provided for lifetime, past year, and...

These detailed tables present totals and prevalence estimates of risk and protective factors regarding substance use from the 2012 National Survey on Drug Use and Health (NSDUH). The factors include perceptions of 1) risk of substance use, 2) availability of substances, 3) parental disapproval of youth substance use, 4) peer...

These detailed tables present totals and prevalence estimates of substance use initiation from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants...

These detailed tables present totals and prevalence estimates of substance dependence/abuse and treatment need/receipt from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Results...

This report presents current and prior methodological approaches for estimating the prevalence of serious mental illness (SMI) and any mental illness (AMI) among adults aged 18 or older using 2008 to 2012 National Survey on Drug Use and Health (NSDUH) data. Revised SMI and AMI estimates for 2012 are presented...

This Data Spotlight focuses on trends in substances of abuse among pregnant women and women of childbearing age (aged 15-44) from 2000 through 2010 using data from the Treatment
Episode Data Set (TEDS).

This publication provides behavioral health statistics at the national and state levels from multiple data sources, including the National Survey on Drug Use and Health, the National Health Interview Survey, the Medical Expenditures Panel Survey, the National Association of State Mental Health Program Directors, as well as peer-reviewed journal articles.

These detailed tables are population illicit drug use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Illicit drugs include marijuana, cocaine, crack, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type psychotherapeutics, including pain relievers, tranquilizers, stimulants, and sedatives. Results are provided for...